Source link : https://www.newshealth.biz/health-news/expert-guidance-issued-for-real-world-use-of-donanemab/
An expert workgroup has developed the first appropriate use recommendations (AURs) for real-world use of the antiamyloid donanemab (Kisunla). “The role of appropriate use recommendations are to bridge the gap between clinical trials and clinical practice,” said guideline author Gil Rabinovici, MD, with the Department of Neurology, University of California, San Francisco. “We know that […]
Author : News Health
Publish date : 2024-10-30 16:07:29
Copyright for syndicated content belongs to the linked Source.